kimi_held, not concerning your thread here, but I don't know how else to reach you. I have been reading a UK diabetes board, and some people there say they are getting Afrezza now. Does the UK have a different drug approval process from the European continent? I think you are in Germany, but I am not sure whether Germany goes through Brussels for drug approvals.
kepler2stars, the natural stomach hormone, oxyntomodulin, that regulates hunger, also known as being full, would be a far better drug to take rather than any of these obesity drugs that are coming out recently. When I read about these new molecules' side effects coming out of phase 2 and 3 trials, these drugs are scary to take.
factspls88, Brian Sullivan brought MNKD up as the worst performing biotech in the past month. That happened 20 min 30 seconds before the opening bell. Cramer, sitting next to him, fumbled around and at first said the product was for asthma. Then he said breathalyzer. Then Cramer said I want to get that product use right which he did not, but he clearly was not thinking diabetes. Seems clear Cramer knows nothing other than what someone put in his head, and he has done no further research. If you guys want to listen to Cramer for anything other than his trying to move a stock up or down, you will be listening to someone who has done no analysis of Afrezza and MNKD.
factspls88, the very day of the Afrezza Adcom the same CNBC guy sitting next to Cramer this morning, Brian Sullivan, during his Streetsigns program showed MNKD downgraded by some analyst who said Afrezza would be rejected by the FDA Adcom. Sullivan even mentioned on that April day he ordinarily would not show a small cap stock, but this analyst downgraded due to his speculation Afrezza would be rejected. So just consider the history.
harden_colten1, while you were hanging out in the bathroom at Four Corners those guys just told you they were doctors.
nialla44, I distinctly heard one of the endocrinologists at the Adcom say jokingly he was concerned Afrezza could put him out of business. I thought it was the endo from San Diego, but I read the entire transcript provided by viettanh9 and did not find such words. I know I heard it, but is it omitted from the transcript or did I just miss it?
getrichq, got it. It is all clear now. I hope even your Lantus dose can be eliminated should your insulin resistance normalize with your lower blood glucose range. That would be pretty cool.
getrichq, I hope you will pardon my not understanding. Are you taking Humulin for basal? Humalog is a so called rapid acting insulin analog for meal times, and I suppose you could be taking Humalog with Afrezza too. However I am just trying to clarify.
If in fact you are taking Afrezza and Humulin, and your basal dose is now cut in half, you may be experiencing what Afrezzauser's doctor wrote about reducing or eliminating insulin resistance.
getrichq, I can understand several reasons why you, a T2, would be using both Afrezza and injecting a basal insulin analog. However are you certain you cannot use or try Afrezza alone for prandial and temporary highs? Is your liver's glucose not-at-meal-times output too much for your natural pancreatic insulin secretion to keep you in a reasonable blood glucose range?
cphammer, you must know, I am assuming you do know, that MNKD/SNY could not present anything like this without some clinical data, and that won't be present at SNY/MNKD at this time. A diabetes doctor with patients and good documentation or some type of diabetes researcher could present such information at a venue such as the ADA, but it cannot be MNKD/SNY at this time. SNY has plenty of assignments by the FDA to trial, and that will keep them busy for a while.
hijack warning: charles_lacey2003 is attempting to hijack charles_lacy2003 's handle. Post from hijacker is below unless he deletes it later.
totellthetruth23, why are you only using Afrezza for your big dinner meal? Is the reason the finger sticks that hurt so much?
getrichq, options market makers. Ever wonder why you won't have a problem buying puts or selling uncovered (naked) calls? There are more ways than just that.
Yes, I suppose more of you cash account guys released more shares to the shorts too. That's another possibility -- supply increased. Regardless whether your shares are borrowed or not, you will get paid the same.
There must not be so much demand from short sellers to borrow to short more MNKD. I suppose some covering has gone on in very recent days.
dfa_69, you indicated here a couple of weeks ago that you work at Sanofi. Did you get this memo that you copied and pasted from a computer?
millionairtobe, of course I am happy to see the good reviews for Afrezza, because I have studied and know from actual users how effective Afrezza is. However I expect some jerk offs to post bogus and negative reviews, and I just wonder how WebMD verifies reviewers for various drugs. It can work both ways, and good verification is always a good thing.
boris821, I recognize eric as Eric Fenar and his review is just like he posts on his twitter account, but on the others I cannot identify how are we to know that WebMD has verified these reviewers? I hope they do a better job than sites like yelp.
slobbermutt, metformin has always been known to be dangerous to the liver, pancreas, and kidneys with plenty of other side effects too. However for type 2s who would not use injected prandial insulin and/or injected basal insulin, it was the least bad choice for type 2s to try to bring blood sugars down. Many doctors know metformin puts many type 2s on the road to becoming type 1s.
apomyster, it is difficult to imagine taking all those drugs each day or week. I just know I would refuse to do it unless I saw some improvement in my blood glucose. Metformin is surely not doing your liver or pancreas any good.